Cadila Pharma's Esiloc wins "Best Launch of the Year"
Esiloc was launched at the biggest doctor engagement webinar involving more than 12,000 doctors across the country
Esiloc was launched at the biggest doctor engagement webinar involving more than 12,000 doctors across the country
The booster vaccination trial is still ongoing and further data will provide more information around safety and efficacy.
This will be an added advantage for Supriya Lifescience Limited in the European market.
Our strategy to drive therapy and brand-focused expansion will continue to show results, especially in the domestic business.
This new facility integrates multi-channel chip, micro-mixer system, and complex preparation system into a multi-channel micro-mixer core LNP manufacturing platform
The drug is expected to cater to the fast growing Rheumatoid Arthritis, Plaque Psoriasis, JIA, Psoriatic Arthritis, Ankylosing Spondylitis, Ulcerative Colitis, Crohns disease, HS and Uveitis markets
DEP® ADCs exploit the unique potential of Starpharma's DEP® technology to provide enhanced characteristics to ADCs i
Urged stakeholders to come up with similar digital platforms and create homegrown best practices where Indian methods and Indian solutions dominate the digital spaces
India imported medical devices worth Rs. 63,200 crore in 2021-22, up 41% from Rs. 44,708 crore in 2020-21
Subscribe To Our Newsletter & Stay Updated